4.4(top 10%)
impact factor
1.9K(top 10%)
papers
24.6K(top 10%)
citations
64(top 10%)
h-index
4.5(top 10%)
extended IF
2.0K
all documents
28.6K
doc citations
110(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1Cancer nanomedicine: a review of recent success in drug deliveryClinical and Translational Medicine2017703
2Mechanisms of chemoresistance in cancer stem cellsClinical and Translational Medicine2013608
3EMT and tumor metastasisClinical and Translational Medicine2015588
4A perspective on multi‐target drug discovery and design for complex diseasesClinical and Translational Medicine2018481
5Significance of long chain polyunsaturated fatty acids in human healthClinical and Translational Medicine2017345
6Analyses of repeated failures in cancer therapy for solid tumors: poor tumor‐selective drug delivery, low therapeutic efficacy and unsustainable costsClinical and Translational Medicine2018337
72019 novel coronavirus of pneumonia in Wuhan, China: emerging attack and management strategiesClinical and Translational Medicine2020282
8The role of CD133 in cancer: a concise reviewClinical and Translational Medicine2018257
9Rapid, responsive, relevant (R3) research: a call for a rapid learning health research enterpriseClinical and Translational Medicine2013230
10Single‐cell RNA sequencing technologies and applications: A brief overviewClinical and Translational Medicine2022218
11Autophagy and inflammationClinical and Translational Medicine2017217
12SOX2 and cancer: current research and its implications in the clinicClinical and Translational Medicine2014213
13Recent advances in hyaluronic acid based therapy for osteoarthritisClinical and Translational Medicine2018193
14Inflammation in chronic obstructive pulmonary disease and its role in cardiovascular disease and lung cancerClinical and Translational Medicine2015187
15Extracellular vesicles as circulating cancer biomarkers: opportunities and challengesClinical and Translational Medicine2018178
16Let‐7 as biomarker, prognostic indicator, and therapy for precision medicine in cancerClinical and Translational Medicine2019172
17Contribution of uric acid to cancer risk, recurrence, and mortalityClinical and Translational Medicine2012160
18A review of research on salivary biomarkers for oral cancer detectionClinical and Translational Medicine2014159
19Hypoxia as a barrier to immunotherapy in pancreatic adenocarcinomaClinical and Translational Medicine2019155
20Combination therapy to checkmate Glioblastoma: clinical challenges and advancesClinical and Translational Medicine2018148
21Clinical significance of epithelial‐mesenchymal transitionClinical and Translational Medicine2014142
22Emerging therapeutic roles for NAD+ metabolism in mitochondrial and age‐related disordersClinical and Translational Medicine2016142
23Clinical significance of monocyte heterogeneityClinical and Translational Medicine2015136
24Mitochondrial transplantation for therapeutic useClinical and Translational Medicine2016134
25The significance of macrophage polarization subtypes for animal models of tissue fibrosis and human fibrotic diseasesClinical and Translational Medicine2015130
26Cytosolic DNA‐STING‐NLRP3 axis is involved in murine acute lung injury induced by lipopolysaccharideClinical and Translational Medicine2020130
27Mitochondria, cholesterol and cancer cell metabolismClinical and Translational Medicine2016127
28Horizontal transfer of RNA and proteins between cells by extracellular microvesicles: 14 years laterClinical and Translational Medicine2016127
29Osteocrin attenuates inflammation, oxidative stress, apoptosis, and cardiac dysfunction in doxorubicin‐induced cardiotoxicityClinical and Translational Medicine2020124
30The impact of saliva collection and processing methods on CRP, IgE, and Myoglobin immunoassaysClinical and Translational Medicine2012123
31Pyroptosis, metabolism, and tumor immune microenvironmentClinical and Translational Medicine2021119
32Haemophilus influenzae and the lung (Haemophilus and the lung)Clinical and Translational Medicine2012118
33The noncoding and coding transcriptional landscape of the peripheral immune response in patients with COVID‐19Clinical and Translational Medicine2020115
34Mechanoregulation and pathology of YAP/TAZ via Hippo and non‐Hippo mechanismsClinical and Translational Medicine2018113
35NLRP3 inflammasome, an immune‐inflammatory target in pathogenesis and treatment of cardiovascular diseasesClinical and Translational Medicine2020113
36CD73 alleviates GSDMD‐mediated microglia pyroptosis in spinal cord injury through PI3K/AKT/Foxo1 signalingClinical and Translational Medicine2021113
37Biomechanics of TGFβ‐induced epithelial‐mesenchymal transition: implications for fibrosis and cancerClinical and Translational Medicine2014112
38Rapamycin and mTOR: a serendipitous discovery and implications for breast cancerClinical and Translational Medicine2012111
39Hallmarks of epithelial to mesenchymal transition are detectable in Crohn's disease associated intestinal fibrosisClinical and Translational Medicine2015108
40Epithelial Mesenchymal Transition: a double‐edged swordClinical and Translational Medicine2015107
41Lipidomics unveils the complexity of the lipidome in metabolic diseasesClinical and Translational Medicine2018106
42Clinical proteomic biomarkers: relevant issues on study design & technical considerations in biomarker developmentClinical and Translational Medicine2014105
43COVID‐19 critical illness pathophysiology driven by diffuse pulmonary thrombi and pulmonary endothelial dysfunction responsive to thrombolysisClinical and Translational Medicine2020105
44Role of maspin in cancerClinical and Translational Medicine2013100
45MELK—a conserved kinase: functions, signaling, cancer, and controversyClinical and Translational Medicine201599
46Oncolytic viruses and checkpoint inhibitors: combination therapy in clinical trialsClinical and Translational Medicine201896
47Emerging roles of exosomal miRNAs in diabetes mellitusClinical and Translational Medicine202195
48Evaluation of the safety and efficacy of using human menstrual blood‐derived mesenchymal stromal cells in treating severe and critically ill COVID‐19 patients: An exploratory clinical trialClinical and Translational Medicine202190
49METTL1 promotes hepatocarcinogenesis via m7G tRNA modification‐dependent translation controlClinical and Translational Medicine202189
50JNK inhibition reduces lung remodeling and pulmonary fibrotic systemic markersClinical and Translational Medicine201688